COVID-19’s Impact on Healthcare Costs with GT Laborde, Chief Executive Officer at IllumiCare
In this episode, we are joined by G.T. LaBorde, CEO at IllumiCare where they help make the cost of care transparent to providers. The company helps providers gain clinical and financial insights as to the cheaper alternatives and most appropriate medication.
G.T. shares some data gathered from 10 health systems covering about 180 hospitals from seven different states that are geographically dispersed. The data includes the cost of care and length of stay of COVID patients. G.T. Also covers some well-known medications used in treating COVID patients, what they are for, and the cost involved. We got into specifics in this interview, and you’ll learn a lot from IllumiCare’s data sets, so please tune in!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
